Đang chuẩn bị liên kết để tải về tài liệu:
Menacalc, a quantitative method of metastasis assessment, as a prognostic marker for axillary node-negative breast cancer

Menacalc is an immunofluorescence-based, quantitative method in which expression of the noninvasive Mena protein isoform (Mena11a) is subtracted from total Mena protein expression. Previous work has found a significant positive association between Menacalc and risk of death from breast cancer |